EGFR and neoplasm: Due to this inhibitory ability, (+)-aeroplysinin-1 was found to have a strong antitumor effect on EGFR tumor cell lines, in particular blocking the proliferation of EGFR dependent human breast cancer cell lines MCF-7 and ZR-75-1 [79].